Bellerophon Therapeutics, Inc.: cashflow_operating

Value{"amount": -8408000, "concept": "us-gaap:NetCashProvidedByUsedInOperatingActivities", "currency": "USD"}
Period2022-01-01 – 2022-06-30
Statuscurrent
EntityBellerophon Therapeutics, Inc.
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference: 0001558370-22-013565 · Open the official SEC filing →
Retrieved: 2026-08-19T16:22:44.668338+02:00
Raw response sha256: f7bde1a401b286c74a2fd824ee1df541…
Also addressable by official identifiers: https://factanker.com/fact/sec/cik-0001600132/cashflow-operating/2022-06-30 (CIK, metric, reporting date)
Cite as: FACTANKER, https://factanker.com/fact/f6d36712-a6e0-43fd-b7fb-c9f059fc7fb6

History

From the Record
32 US software companies haven’t lost money in a decade. One of them is steadier than all the rest.
Read the findingSearch 53 million companies